Best Liver cancer stage 2 Doctors in Israel — TOP 18

Dr. Pelles Sharon specializes in complex liver cancer treatments, including advanced techniques like SIRT therapy and liver resection at Sourasky Medical Center.

• Highly respected oncologist with extensive clinical research contributions
• Provides innovative treatments like Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
• Expert in chemotherapy for liver cancer and radiofrequency ablation
• Offers comprehensive care with targeted therapy and immunotherapy options

Prof. Merimsky leads the Unit for Soft Tissue and Bone Oncology at Sourasky Medical Center – one of Israel's top cancer treatment hospitals.

• Over 41 years of experience specializing in complex oncology cases
• Fellowship-trained at Institut Gustave Roussy for sarcoma treatment
• Vice Chairman of the hospital's Ethical Committee
• Published numerous papers on bone and soft tissue tumors
• Faculty member of ESMO's Sarcoma group

Over 44 years of experience of experience focused on gastrointestinal cancers. He leads the Cancer Prevention Center at Sourasky Medical Center (Ichilov).

• Specializes exclusively in prevention, early diagnosis, and treatment of GI tumors
• Author of more than 300 published scientific papers on gastrointestinal oncology
• Completed research work at NewYork-Presbyterian Center in the USA
• Fellowship-trained in gastroenterology at Tel Aviv University's Sackler Faculty of Medicine
• Member of international societies like the European Society of Digestive Oncology

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Leads the Medical Oncology Division at Sourasky Medical Center – one of Israel's leading hospitals. He has specific experience in Oncology and Internal Medicine.

• Board-certified with extensive training including Army Medical Units
• Senior leadership role overseeing all cancer treatment protocols
• Medical degree from Ben Gurion University of the Negev
• Specializes in systemic cancer treatments and therapy coordination

A top specialist in Whipple and minimally invasive abdominal surgery, Dr. Greenberg heads the Colorectal Surgery Department at Sourasky Medical Center (Ichilov).

• Over 35 years of experience of experience as an abdominal surgeon
• Performs both open and minimally invasive surgical techniques
• Expert in complex pancreatic and liver procedures like Whipple surgery
• Leads a specialized surgical department at a major hospital

32 years of experience specializing in liver cancer surgery – Dr. Ben-haim is among Israel's top gastrointestinal cancer surgeons at Sourasky Medical Center.

• Expert in Whipple surgery for complex cases
• Focuses exclusively on liver, pancreatic, and gastrointestinal cancers
• Performs advanced interventions for oncological conditions

Dr. Auala Hubert leads the Gastrointestinal Cancer Center at Hadassah Medical Center, bringing 36 years of experience of focused oncology expertise.

• Specializes in Medical Oncology & Radiotherapy
• Head of Gastrointestinal Cancer Center at Hadassah
• Board-certified in Oncology & Radiotherapy
• Member of Israel Society of Clinical Oncology
• Fluent in English and Hebrew for international patients

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Alexander Beny is a Board Certified Oncologist with extensive training in medical and radiation oncology, specializing in liver cancer at Rambam Medical Center.

• Head of Gastrointestinal Malignant Service at Rambam Medical Center
• Trained in Italy and Israel with European board certification
• Specializes in both medical and radiation oncology approaches
• Leads dedicated gastrointestinal and onco-gynecology clinics

Dr. Zalmanova specializes in radiotherapy at Assuta Medical Center, focusing on liver cancer treatments.

• Radiotherapist with expertise in liver cancer stage 2
• Works at Assuta Medical Center, a leading healthcare facility
• Dedicated to personalized treatment plans for each patient